Genomic characterization of human immunodeficiency virus 1 and human T-lymphotropic virus 1 simultaneous integration
PDF (Español (España))

How to Cite

Domínguez, M. C., Alzate, L. A., & Garcia - Vallejo, F. (2015). Genomic characterization of human immunodeficiency virus 1 and human T-lymphotropic virus 1 simultaneous integration. Revista De La Academia Colombiana De Ciencias Exactas, Físicas Y Naturales, 39(151), 239–249. https://doi.org/10.18257/raccefyn.183

Downloads

Download data is not yet available.

Métricas Alternativas


Dimensions

Abstract

The selection of retroviral cDNA integration sites in the human genome is a critical step to condition the dynamics of infection. The objective was to analyze the combination of genomic characteristics of infected cells that would condition the genomic profiles of HIV-1/HTLV-1 simultaneous integration. We carried out a computer simulation using 203 human genome sequences flanking 3´LTR of both retroviruses previously deposited in the GenBank, and applying several computational tools. The analyses were focused on determining the chromosomal integration, CpG islands, Alu sequences and the expression of integration target class II genes in lymphocytic populations in a 100 kb chromatin structure associated with simultaneous integration. We found 47.3% of simultaneous cDNA integrations localized in regions rich in repetitive elements. The rest of retroviral cDNA integrations occurred in class II gene introns (p<0.05). We determined a differential chromosomal distribution for both types of provirus where HTLV-1 provirus were preferentially placed in pericentromeric and centromeric regions in contrast with HIV-1 distribution, which was registered in telomeric and subtelomeric zones (p<0.001). The genomic environment of integration for both retroviruses was characterized by genes encoding molecular binding and signal transduction, as well as by high density of CpG islands and Alu sequences. The data resulting from the computer simulation did support the hypothesis that a combination of specific chromatin characteristics would determine the dynamics of HIV-1/HTLV-1 simultaneous integration process.
https://doi.org/10.18257/raccefyn.183
PDF (Español (España))

References

Ambrosi A., Cattoglio C., Di Serio C. 2008. Retroviral integration process in the human genome: Is it really non-random? A new statistical approach. PLoS Comput. Biol. 4: e1000144.

Barr S., Ciuffi A., Leipzig J., Shinn P., Ecker J., Bushman F. 2006. HIV Integration site selection: Targeting in macrophages and the effects of different routes of viral entry. Mol. Ther. 14: 218-25.

Batzer M.A. & Deininger P.L. 2002. Alu repeats and human genomic diversity. Nat. Rev. Genet. 3: 370-9.

Biasco L., Baricordi C., Aiuti A. 2012. Retroviral integrations in gene therapy trials. Mol. Ther. 20 (4): 709-16.

Brites C., Sampalo J., Oliveira A. 2009. HIV/human T-cell lymphotropic virus coinfection revisited: Impact on AIDS progression. AIDS Rev. 11 (1): 8-16.

Brites C., Harrington Jr. W., Pedroso C., Netto E.M., Badaró R. 1997. Epidemiological characteristics of HTLV-I and II coinfection in Brazilian subjects infected by VIH-1. Braz. J. Inf. Dis. 1: 42-7.

}

Bushman F., Lewinski M., Ciuffi A., Barr S., Leipzig J., Hannenhalli S., et al. 2005. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3: 848-58.

Cabrera-Moncayo J., Hiroshi M., Cerón F., Castillo A., Baba M., Akiba S., et al. 2004. Características moleculares de los sitios de integración del virus linfotrópico humano tipo I en linfocitos naturalmente infectados. Rev. Asoc. Col. Cienc. Biol. 16: 91-98.

Casoli C., Pilotti E., Bertazzoni U. 2007. Molecular and cellular interactions of VIH-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 9: 140-9.

Cattoglio C., Pellin D., Rizzi E., Maruggi G., Corti G., Miselli F., et al.

High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood. 116: 5507-17.

Cavrois M., Gessain A., Gout O., Wain-Hobson S., Wattel E. 2000. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis. 182: 1044-50.

Cavrois M., Wain-Hobson S., Wattel E. 1995. Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol. 146: 179-8.

Ciuffi A., Mitchell R., Hoffmann C., Leipzig J., Shinn P., Ecker J., Bushman F. 2006. Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol. Ther. 13: 366-73.

Craig J. & Bickmore W. 1994. The distribution of CpG in mammalian chromosome. Nature Genet. 7: 376-82.

Crise B., Y. Li C., Yuan D.R., Morcock D., Whitby D.J., Munroe L.O., et al. 2006. Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J. Virol. 79: 12199-204.

Dagarag M., Evazyan T., Rao N., Effros R.B. 2004. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: Enhanced antiviral functions accompany the Iicreased proliferative potential and telomere length stabilization. J. Immunol. 173: 6303-11.

Daniel R. & Smith JA. 2008. Integration site selection by retroviral vectors: Molecular mechanism and clinical consequences. Hum. Gene Ther. 19: 557-68.

Debyser Z., Christ F., De Rijck J., Gijsbers R. 2015. Host factors for retroviral integration site selection. Trends Biochem. 40: 108-16.

Derse D., Crise B., Li Y., Princler G., Stewart C., Connor F., et al. 2007. HTLV-1 integration target sites in the human genome: Comparison with other retroviruses. J. Virol. 81: 6731-41.

Effros R.B., Allsopp R., Chiu C.P., Hausner M.A., Hirji K., Wang L., et al. 1996. Shortened telomeres in the expanded CD28- CD8- cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 10: F17.

Eller C.D., Regelson M., Merriman B., Nelson S., Horvath S., Marahrens Y. 2007. Repetitive sequence environment distinguishes housekeeping genes. Gene. 390: 153-65.

Friedman J., Cho W.K., Chu C.K., Keedy K.S., Archin N.M., Margolis D.M., Karn J. 2011. Epigenetic silencing of VIH-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J. Virol. 85: 9078-89.

Gagniuc P & Ionescu-Tirgoviste C. 2013. Gene promoters show chromosome-specificity and reveal chromosome territories in humans. BMC Genomics. 14: 27.

Giri M.S., Nebozhyn M., Showe L., Montaner L.J. 2006. Microarray data on gene modulation by HIV-1 in immune cells: 2000–2006. J. Leukoc. Biol. 80: 1031-43.

Góngora-Bianchi R.A., Sosa-Cantón O., Pavía-Ruz N., Vera-Gamboa L., Lara-Perera D. 2003. Factores asociados con el riesgo de infección por retrovirus (VIH- 1 y HTLV-I/II) y su prevalencia en sexo trabajadoras de Campeche, México, en 1996-1997. Rev. Biomed. 14: 239-6.

Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 302: 415-9.

Haller C., Müller B., Fritz J.V., Lamas-Murua M., Stolp B., Pujol F.M., et al. 2014. HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J Virol. 88: 14241-57.

Hanai S., Nitta T., Shoda M., Tanaka M., Isu N., Mizoguchi I., et al. 2004. Integration of human T-cell leukemia virus type I in genes of leukemia cells of patients with adult T-cell leukemia. Cancer Sci. 95: 306-10.

Hindmarsh P. & Leis J. 1999. Retroviral DNA integration. Microbiol. Mol. Biol. Rev. 63: 836-84. Hochstein N., Muiznieks I., Mangel L., Brondke H., Doerfler W.2007. The epigenetic status of an adenovirus transgenome upon long-term cultivation in hamster cells. J. Virol. 81: 5349-61.

Ikeda T., Shibata J., Yoshimura K., Koito A., Matsushita S.2007. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis. 195: 716-25.

International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature. 409: 860-921.

Kumar P.P., Mehta S., Purbey P.K., Ranveer D.N., Jayani S., Purohit H.J., et al. 2007. ATB1-binding sequences and Alu-like motifs define a unique chromatin context in the vicinity of human immunodeficiency virus type 1 Integration Sites. J. Virol. 81: 5617-27.

Laurentino R.V., Lopes I.G., Azevedo V.N., Machado L.F., Moreira M.R., Lobato L., et al. 2005. Molecular characterization of human T-cell lymphotropic virus coinfecting human immunodeficiency virus 1 infected patients in the Amazon region of Brazil. Mem. Inst. Oswaldo Cruz. 100: 371-6.

Lefrère J.J., Couroucê A.M., Mariotti M., Wattel E., Prou O., Bouchardeau F., et al.1990. Rapid progression to AIDS in dual VIH-1/HTLV-I infection. Lancet. 336: 509.

Lewinski M.K., Yamashita M., Emerman M., Ciuffi A., Marshall H., Crawford G., et al. 2006. Retroviral DNA integration: Viral and cellular determinants of target-site selection. PLoS Pathogens. 2: e60.

Le Friec G., Sheppard D., Whiteman P., Karsten C.M., Shamoun S.A., Laing A., et al. 2012. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol.13: 1213-21.

Meekings K.N., Leipzig J., Bushman F.D., Taylor G.P., Bangham C. 2008. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathol. 4: e1000027.

Mitchell R.S., Beitzel B.F., Schroder A.R., Shinn P., Chen H., Berry C.C., et al. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2: e234.

Moriuchi H., Moriuchi M., Fauci A.S. 1998. Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of VIH-1 in HTLV-I-uninfected cells: Implications for in vivo coinfection with HTLV-I and VIH-1. J. Exp. Med. 187: 1689-97.

Mortreux F., Leclercq I., Gabet A.S., Leroy A., Westhof E., Gessain A., et al. 2001. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst. 93: 367-77.

Nagel J., Gross B., Meggendorfer M., Preiss C., Grez M., Brack-Werner R., et al. 2012. Stably integrated and expressed retroviral sequences can influence nuclear location and chromatin condensation of the integration locus. Chromosoma. 121 (4): 353-67.

Nienhuis A.W., Dunbar C.E., Sorrentino B.P. 2006. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 13: 1031-49.

Ozawa T., Itoyama T., Sadamori N., Yamada Y., Hata T., Tomonaga M., et al. 2004. Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci. J Hum Genet. 49: 154-65.

Pavlice K.A., Jabbari K., Paces J., Hejnar J., Bernardi G. 2001. Similar integration but different stability of Alus and LINEs in the human genome. Gene. 276: 39-45.

Pedroso C., Netto E.M., Weyll N., Brites C. 2011. Coinfection by VIH-1 and human lymphotropic virus type 1 in Brazilian children is strongly associated with a shorter survival time. J. Acquir. Immune Defic. Syndr. 57 Suppl 3: S208-11.

Pilotti E., Bianchi M.V., De Maria A., Bozzano F., Romanelli M.G., Bertazzoni U., et al. 2013. HTLV-1/-2 and VIH-1 co-infections: Retroviral interference on host immune status. Front. Microbiol. 4: 372.

Pryciak P.M. & Varmus H.E. 1992. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell. 69: 769-80.Riethman H. 2008. Human telomere structure and biology. Annu, Rev. Genomics Human Genetics. 9: 1-19.

Rynditcha A., Zoubaka S., Tsybaa L., Tryapitsina-Guleya N., Bernardi G. 1998. The regional integration of retroviral sequences into the mosaic genomes of mammals. Gene. 22: 1-16.

Salcedo-Cifuentes M., Domínguez M.C., García-Vallejo F.2011. Genomic epidemiology of the HTLV-1 integration process in TSP/HAM cases. Pan Am. J. Public Health. 30: 422-30.

Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., Bushman F. 2002. VIH-1 integration in the human genome favors active genes and local hotspots. Cell. 110: 521-29.

She X., Rohl C.A., Castle J.C., Kulkarni A.V., Johnson J.M., Chen R. 2009. Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics. 10: 269.

Sierra S., Kupfer B., Kaiser R. 2005. Basics of the virology of VIH-1 and its replication. J. Clin. Virol. 34: 233-44.Simons A., Shaffer L.G., Hastings R.J. 2013. Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition. Cytogenet. Genome Res. 141: 1-6.

Slattery J., Franchini G., Gessain A. 1999. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell Leukemia/Lymphotropic Viruses. Genome Res. 9: 525-40.

Soto J., Peña A., García-Vallejo F. 2011. A genomic and bioinformatics analysis of the integration of HIV in peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses. 27: 547-55.

Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA. 101: 6062-7.

Tsukasaki K., Tssima H., Yamamura M., Hata T., Murata K., Maeda T., et al. 1997. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: Frequent clonal change at crisis from indolent disease. Blood. 89: 948-56.

Van Maele B., Busschots K., Vandekerckhove L., Christ F., Debyser Z. 2006. Cellular co-factors of VIH-1 integration. Trends Biochem. Sci. 31: 98-105.

Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. 2001. The sequence of the human genome. Science. 291: 1304-51.

Wang G.P., Ciuffi A., Leipzig J., Berry C.C., Bushman F.D. 2007. HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 17: 1186-94.

Weber S., Weiser B., Kemal K.S., Burger H., Ramírez C.M., Korn K., et al. 2014. Epigenetic analysis of VIH-1 proviral genomes from infected individuals: predominance of unmethylated CpG’s. Virology. 449: 181-9

Wu X. & Burgess S.M. 2004. Integration target sites selection for retroviruses and transposable elements. Cell. Mol. Life Sci. 61: 2588-96.

Declaration of originality and transfer author's rights

The authors declare:

  1. The published data and reference materials have been duly identified with their respective credits and have been included in the bibliographic notes and citations that have been so identified and that should it be required, I have all releases and permissions from any copyrighted material. 
  2. All material presented is free from any copyright and that I accept full legal responsibility for any legal claims relating to copyrighted intellectual property, fully exonerating from responsibility the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.
  3. This work is unpublished and will not be sent to any other journal while waiting for the editorial decision of this journal. I declare that there is no conflict of interest in this manuscript.
  4. In case of publication of this article, all author´s rights are transferred to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, and so cannot be reproduced in any form without the express permission of it.
  5. By means of this document, if the article is accepted for publication by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, the Revista assumes the right to edit and publish the articles in national and international indices or data bases for academic and scientific use in paper, electronic, CD-ROM, internet form either of the complete text or any other known form known or to be known and non-commercial, respecting the rights of the authors.

Transfer of author rights

In case the article is approved for publication, the main author in representation of himself and his co-authors or the main author and his co-authors must cede the author rights of the corresponding article to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales, except in the following cases:

The authors and co-authors will retain the right to revise, adapt, prepare derived works, oral presentations, and distribution to some colleagues of reprints of their own published work, if the corresponding credit is given to the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales. It is also permissible to publish the title of the work, summary, tables, and figures of the work in the corresponding web sites of the authors or their employers, also giving credit to the Revista.

If the work has been realized under contract, the author’s employer has the right to revise, adapt, prepare derivative works, reproduce, or distribute in hard copy the published work, in a secure manner and for the exclusive use of his employees.

If the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales were approached for permission by a third party for using, printing, or publishing specifically articles already published, the Revista must obtain the express permission of the author and co-authors of the work or of the employer except for use in classrooms, libraries, or reprinted in a collective work. The Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales reserves the possible use in its front cover of figures submitted with the manuscripts.

No other right, other than the author’s right, can be claimed by the Revista de la Academia Colombiana de Ciencias Exactas, Físicas y Naturales.